Literature DB >> 32706057

The interaction between circular RNA hsa_circ_0000285 and miR-599 in thyroid cancer.

D Yang1, Y Jin, S Cheng, Y Yang.   

Abstract

Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "The interaction between circular RNA hsa_circ_0000285 and miR-599 in thyroid cancer, by D. Yang, Y. Jin, S. Cheng, Y. Yang, published in Eur Rev Med Pharmacol Sci 2020; 24 (9): 4882-4889-DOI: 10.26355/eurrev_202005_21177-PMID: 32432751" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/21177.

Entities:  

Year:  2020        PMID: 32706057     DOI: 10.26355/eurrev_202007_21870

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  4 in total

1.  Hsa_circ_0000285 contributes to gastric cancer progression by upregulating FN1 through the inhibition of miR-1278.

Authors:  Xue Wang; Mao Tan; He Huang; Yanlei Zou; Mengqiao Wang
Journal:  J Clin Lab Anal       Date:  2022-05-09       Impact factor: 3.124

2.  Knockdown of circHECTD1 inhibits oxygen-glucose deprivation and reperfusion induced endothelial-mesenchymal transition.

Authors:  Guo-Hua He; Zhen Wang; Wei Xu; Kang-Ping Song; Hui Xiao
Journal:  Metab Brain Dis       Date:  2022-01-20       Impact factor: 3.584

3.  hsa_circ_0000285 facilitates thyroid cancer progression by regulating miR-127-5p/CDH2.

Authors:  Bowei Zhang; Qiaoling Li; Zhe Song; Li Ren; Yi Gu; Chao Feng; Jinju Wang; Tong Liu
Journal:  J Clin Lab Anal       Date:  2022-04-21       Impact factor: 3.124

4.  Regulation of microRNA miR-197-3p/CDC28 protein kinase regulatory subunit 1B (CKS1B) axis by Circular RNA hsa_circ_0000285 promotes glioma progression.

Authors:  Tao Deng; Yang Liu; Yanlong Yang; Leyong Yuan; Fangfang Liu; Xiaobo Wang; Qiuying Zhang; Mingshui Xie
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.